276 related articles for article (PubMed ID: 34687487)
21. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
22. Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain.
Ramassamy C; Averill D; Beffert U; Theroux L; Lussier-Cacan S; Cohn JS; Christen Y; Schoofs A; Davignon J; Poirier J
Neurobiol Dis; 2000 Feb; 7(1):23-37. PubMed ID: 10671320
[TBL] [Abstract][Full Text] [Related]
23. Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype.
Conejero-Goldberg C; Hyde TM; Chen S; Dreses-Werringloer U; Herman MM; Kleinman JE; Davies P; Goldberg TE
Mol Psychiatry; 2011 Aug; 16(8):836-47. PubMed ID: 20479757
[TBL] [Abstract][Full Text] [Related]
24. Identification and modification of amyloid-independent phenotypes of APOE4 mice.
DiBattista AM; Dumanis SB; Newman J; Rebeck GW
Exp Neurol; 2016 Jun; 280():97-105. PubMed ID: 27085394
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.
Johnson LA; Olsen RH; Merkens LS; DeBarber A; Steiner RD; Sullivan PM; Maeda N; Raber J
Neurobiol Dis; 2014 Apr; 64():150-62. PubMed ID: 24412220
[TBL] [Abstract][Full Text] [Related]
26. Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How.
Lewandowski CT; Maldonado Weng J; LaDu MJ
Neurobiol Dis; 2020 Jun; 139():104811. PubMed ID: 32087290
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
Baum L; Chen L; Ng HK; Pang CP
Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
[TBL] [Abstract][Full Text] [Related]
28. The chemotherapeutic agent doxorubicin induces brain senescence, with modulation by APOE genotype.
Demby T; Gross PS; Mandelblatt J; Huang JK; Rebeck GW
Exp Neurol; 2024 Jan; 371():114609. PubMed ID: 37944881
[TBL] [Abstract][Full Text] [Related]
29. Implications of apolipoprotein E genotype on inflammation and vitamin E status.
Huebbe P; Lodge JK; Rimbach G
Mol Nutr Food Res; 2010 May; 54(5):623-30. PubMed ID: 20183830
[TBL] [Abstract][Full Text] [Related]
30. Aggregate Trends of Apolipoprotein E on Cognition in Transgenic Alzheimer's Disease Mice.
Watson Y; Nelson B; Kluesner JH; Tanzy C; Ramesh S; Patel Z; Kluesner KH; Singh A; Murthy V; Mitchell CS
J Alzheimers Dis; 2021; 83(1):435-450. PubMed ID: 34334405
[TBL] [Abstract][Full Text] [Related]
31. APOE genotype results in differential effects on the peripheral clearance of amyloid-beta42 in APOE knock-in and knock-out mice.
Sharman MJ; Morici M; Hone E; Berger T; Taddei K; Martins IJ; Lim WL; Singh S; Wenk MR; Ghiso J; Buxbaum JD; Gandy S; Martins RN
J Alzheimers Dis; 2010; 21(2):403-9. PubMed ID: 20555142
[TBL] [Abstract][Full Text] [Related]
32. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4.
Olichney JM; Hansen LA; Hofstetter CR; Lee JH; Katzman R; Thal LJ
Arch Neurol; 2000 Jun; 57(6):869-74. PubMed ID: 10867785
[TBL] [Abstract][Full Text] [Related]
33. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
[TBL] [Abstract][Full Text] [Related]
34. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
Keeney JT; Ibrahimi S; Zhao L
J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
[TBL] [Abstract][Full Text] [Related]
35. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.
Tai LM; Bilousova T; Jungbauer L; Roeske SK; Youmans KL; Yu C; Poon WW; Cornwell LB; Miller CA; Vinters HV; Van Eldik LJ; Fardo DW; Estus S; Bu G; Gylys KH; Ladu MJ
J Biol Chem; 2013 Feb; 288(8):5914-26. PubMed ID: 23293020
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.
Arold S; Sullivan P; Bilousova T; Teng E; Miller CA; Poon WW; Vinters HV; Cornwell LB; Saing T; Cole GM; Gylys KH
Acta Neuropathol; 2012 Jan; 123(1):39-52. PubMed ID: 22020632
[TBL] [Abstract][Full Text] [Related]
37. Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.
Thangavel R; Bhagavan SM; Ramaswamy SB; Surpur S; Govindarajan R; Kempuraj D; Zaheer S; Raikwar S; Ahmed ME; Selvakumar GP; Iyer SS; Zaheer A
J Alzheimers Dis; 2018; 61(2):553-560. PubMed ID: 29172001
[TBL] [Abstract][Full Text] [Related]
38. Differential interaction of Apolipoprotein-E isoforms with insulin receptors modulates brain insulin signaling in mutant human amyloid precursor protein transgenic mice.
Chan ES; Chen C; Cole GM; Wong BS
Sci Rep; 2015 Sep; 5():13842. PubMed ID: 26346625
[TBL] [Abstract][Full Text] [Related]
39. APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-κB activation.
Arnaud L; Benech P; Greetham L; Stephan D; Jimenez A; Jullien N; García-González L; Tsvetkov PO; Devred F; Sancho-Martinez I; Izpisua Belmonte JC; Baranger K; Rivera S; Nivet E
Cell Rep; 2022 Aug; 40(7):111200. PubMed ID: 35977506
[TBL] [Abstract][Full Text] [Related]
40. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.
Sawmiller D; Habib A; Hou H; Mori T; Fan A; Tian J; Zeng J; Giunta B; Sanberg PR; Mattson MP; Tan J
Biol Psychiatry; 2019 Aug; 86(3):208-220. PubMed ID: 31208706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
